Back to Peptides
Weight Loss
Setmelanotide
Setmelanotide is a melanocortin-4 receptor (MC4R) agonist approved (as Imcivree) for certain rare genetic causes of obesity. It acts on central appetite-regulating pathways and is studied for its effects on hunger and body weight in melanocortin-pathway deficiencies.
Weight LossMC4RAppetiteSC
Research Benefits
Activates the MC4 receptor appetite pathway
Approved for rare genetic obesity syndromes
Appetite and body-weight effects studied
Melanocortin-pathway research
Axo's Research Digest
An AI-generated, plain-English overview of what the research explores for Setmelanotide — and how mature that evidence is.